Diabetes and hypertension: facing the big challenge ahead

Diabetes and HTN are ‘bad companions’ the prevalence of both are high with devastating consequences and is a challenge to doctors. So, the question is how do we prevent millions of premature deaths? We have tended to focus on BP management, but it is important to find drugs that can provide not only BP control but is more important to find drugs that can save lives and offer cardiovascular protection.

This lecture focused on guideline recommendations for SPC first-line in diabetic HTN patients, and the rational for an ACEIs diuretic combination for BP efficacy, complete renal protection and mortality reduction.

Ref: Williams B, et al. J Hypertens 2018;36(12):2284-309; Williams B, et al. Eur Heart J 2018;39(33):3021-104. Van Vark LC et al. European Heart Journal, Volume 33, Issue 16, August 2012, Pages 2088–2097. Bangalore S, et al. Am J Med. 20210; 123: 1016-1030. Hypertension 2015; 33: 195-211. Tòth K, on behalf of PIANIST Investigators. Am J Cardiovasc Drugs. 2014;14:137–145